CLINICAL_TRIALS
trial_result
· 2022-07-12
Clinical Trial Update: Mechanistic Evaluation of Response in TRD (MERIT) [Phase 2]
Summary
Phase 2 clinical trial evaluating mechanistic response in treatment resistant depression and major depressive disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Axsome Therapeutics, Inc. | Conditions: Treatment Resistant Depression, Major Depressive Disorder | Phase 2 | Status: COMPLETED